POLE-Mutant Colon Cancer Treated with PD-1 Blockade Showing Clearance of Circulating Tumor DNA and Prolonged Disease-Free Interval

By sjmartinez • May 28, 2023

Bikhchandani M, Amersi F, Hendifar A, Gangi A, Osipov A, Zaghiyan K, Atkins K, Cho M, Aguirre F, Hazelett D, Alvarez R, Zhou L, Hitchins M, Gong J. POLE-Mutant Colon Cancer Treated with PD-1 Blockade Showing Clearance of Circulating Tumor DNA and Prolonged Disease-Free Interval. Genes (Basel). 2023 May 8;14(5):1054. doi: 10.3390/genes14051054. PMID: 37239414; PMCID: PMC10218075.

Tags: Cedars Sinai DoM, Checkpoint Inhibitor, Colon cancer, Hematology/Oncology, high tumor mutation burden, immunotherapy, MSS, POLE, Publications

Psychosocial and clinical characteristics in Takotsubo syndrome

Obrutu O, Cui Y, Maughan J, Marano P, Wei J, Gulati M, Lauzon M, Herscovici R, Shufelt C, Rojas N, Tjoe B, Rutledge T, Bairey[...]

Loss of TRIM21 drives UVB-induced systemic inflammation by regulating DNA-sensing pathways

Tumurkhuu G, Perri G, Moore R, Huo L, Kumar AN, Ainsworth R, Oliver T, de Los Santos G, Gibb D, Carriere J, Yu JM, Abuav[...]

Reply to the letter to the editor on “Re: “Sex Disparities in Alcohol-Associated Liver Disease and Subtype Differences in Alcohol-attributable Cancers in the United States”

Danpanichkul P, Diaz LA, Arab JP, Singal AG, Yang JD. Reply to the letter to the editor on "Re: "Sex Disparities in Alcohol-Associated Liver Disease[...]